dc.contributor.author | Kamanda, Martin I | |
dc.contributor.author | Muriithi, Ian M | |
dc.date.accessioned | 2018-01-18T08:36:57Z | |
dc.date.available | 2018-01-18T08:36:57Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | Kamanda MI, Mathenge MI. Simultaneous occurrence of five prothrombotic induced vaso-occlusive phenomena and focal nodular hyperplasia due to prolonged use of combined oral contraceptive pills. BJR Case Rep 2017; 3: 20170070. | en_US |
dc.identifier.uri | http://hdl.handle.net/11295/102375 | |
dc.description.abstract | This is a rare case of a patient simultaneously presenting with five complications associated with the prolonged (5 years)
use of combined oral contraceptives. The two main ingredients of combined oral contraceptives responsible for
thromboembolism are estrogen (estradiol) and progestogen (progestin). Progestins are linked with occlusion of arteries
while estrogens can induce both arterial and venous thrombosis. This case represents a patient with portal vein
thrombosis, superior mesenteric vein thrombosis, coeliac artery occlusion, splenic and jejunal infarction and focal nodular
hyperplasia. | en_US |
dc.language.iso | en | en_US |
dc.publisher | University of Nairobi | en_US |
dc.title | Simultaneous occurrence of five prothrombotic induced vaso-occlusive phenomena and focal nodular hyperplasia due to prolonged use of combined oral contraceptive pills | en_US |
dc.type | Article | en_US |